Romatolojik Hastalıkların Nörolojik Manifestasyonları: Antifosfolipid Antikor Sendromu Olan Hastalarda Nörolojik Tutulum

Tadej Avcin, Kathleen M. O’Neil (2021). Antiphospolipid Syndrome In: Petty RE, Laxer RM, Lindsley CB, Wedderburn L, Fuhlbrigge RC, Mellins ED. (eds) Textbook of pediatric rheumatology Vol:8 Elsevier Health Sciences; Philedelphia.

Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1999 Jul;42(7):1309-11.

Miyakis S, Lockshin MD, Atsumi T, et al. International consensusstatement on an update of the classification criteria for definite anti-phospholipid syndrome. J Thromb Haemost 2006;4:295–306

Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim‐Esen B, Atsumi T. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis & Rheumatology. 2023 Oct;75(10):1687-702.

Groot N, De Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, Kenet G, Koné-Paut I, Lahdenne P, Marks SD, McCann L. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Annals of the rheumatic diseases. 2017 Oct 1;76(10):1637-41.

Ioannou Y, Beukelman T, Murray M, Erkan D. Incidence of antiphospholipid syndrome: is estimation currently possible?. European Journal of Rheumatology. 2023 Jan;10(1):39.

Duarte‐García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, Warrington KJ, Matteson EL. The epidemiology of antiphospholipid syndrome: a population‐based study. Arthritis & Rheumatology. 2019 Sep;71(9):1545-52.

Biggioggero M, Meroni PL. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmunity reviews. 2010 Mar 1;9(5):A299-304.

Avčin T, Cimaz R, Rozman B, Ped-APS Registry Collaborative Group*. The Ped-APS Registry: the antiphospholipid syndrome in childhood. Lupus. 2009 Sep;18(10):894-9.

Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio A, Journeycake J, Junker R, Male C. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. InSeminars in thrombosis and hemostasis 2011 Oct (Vol. 37, No. 07, pp. 802-809). © Thieme Medical Publishers.

Aguiar CL, Soybilgic A, Avcin T, Myones BL. Pediatric antiphospholipid syndrome. Current rheumatology reports. 2015 Apr;17:1-3.

Ahearn J. Speaker Abstracts (SP01–SP50). Rheumatology. 2012 Feb 2;51.

De Meis E, Brandão BC, Capella FC, Garcia JA, Gregory SC. Catastrophic antiphospholipid syndrome in cancer patients: an Interaction of clotting, autoimmunity and tumor growth?. The Israel Medical Association Journal: IMAJ. 2014 Sep 1;16(9):544-7. 20

Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. InSeminars in arthritis and rheumatism 2006 Apr 1 (Vol. 35, No. 5, pp. 322-332). WB Saunders.

Bitsadze V, Yakubova F, Khizroeva J, Lazarchuk A, Salnikova P, Vorobev A, Tretyakova M, Degtyareva N, Grigoreva K, Gashimova N, Kvaratskheliia M. Catastrophic Antiphospholipid Syndrome. International Journal of Molecular Sciences. 2024 Jan 4;25(1):668.

Sloan EE, McCurdy D. The antiphospholipid syndrome in the pediatric population. Advances in pediatrics. 2022 Aug 1;69(1):107-21.

Chaturvedi S, McCrae KR. Diagnosis and management of the antiphospholipid syndrome. Blood reviews. 2017 Nov 1;31(6):406-17.

Cousins L, Pericleous C, Khamashta M, Bertolaccini ML, Ioannou Y, Giles I, Rahman A. Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’antiphospholipid syndrome. Annals of the rheumatic diseases. 2015 Jan 1;74(1):317-9.

Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. New England Journal of Medicine. 2013 Mar 14;368(11):1033-44.

Devreese KM, de Groot PG, de Laat B, Erkan D, Favaloro EJ, Mackie I, Martinuzzo M, Ortel TL, Pengo V, Rand JH, Tripodi A. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. Journal of thrombosis and haemostasis. 2020 Nov 1;18(11):2828-39.

Avcin T, Cimaz R, Silverman ED, Cervera R, Gattorno M, Garay S, Berkun Y, Sztajnbok FR, Silva CA, Campos LM, Saad-Magalhaes C. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008 Nov 1;122(5):e1100-7.

Ma J, Song H, Wei M, He Y. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Clinical Rheumatology. 2018 May;37:1295-303.

Dragoni F, Chiarotti F, Rosano G, Simioni P, Tormene D, Mazzucconi MG, Cafolla A, Avvisati G. Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: a controlled study. Thrombosis research. 2011 Feb 1;127(2):85-90.

Duran R, Biner B, Demir M, Çeltik C, Karasalihoğlu S. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clinical and applied thrombosis/hemostasis. 2005 Jan;11(1):83-8.

Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OG, Silva GS, de Souza AW, Andrade D. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018 Aug;27(9):1404-14.

Mittal P, Quattrocchi G, Tohidi-Esfahani I, Sayar Z, Chandratheva A, Cohen H. Antiphospholipid syndrome, antiphospholipid antibodies, and stroke. International Journal of Stroke. 2023 Apr;18(4):383-91.

Gris JC, Brenner B. Antiphospholipid antibodies: neuropsychiatric presentations. InSeminars in thrombosis and hemostasis 2013 Nov (Vol. 39, No. 08, pp. 935-942). Thieme Medical Publishers.

Mittal P, Quattrocchi G, Tohidi-Esfahani I, Sayar Z, Chandratheva A, Cohen H. Antiphospholipid syndrome, antiphospholipid antibodies, and stroke. International Journal of Stroke. 2023 Apr;18(4):383-91.

Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OG, Silva GS, de Souza AW, Andrade D. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018 Aug;27(9):1404-14.

Fleetwood T, Cantello R, Comi C. Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy. Frontiers in neurology. 2018 Nov 26;9:1001.

Cervera R, Boffa MC, Khamashta MA, Hughes GR. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009 Sep;18(10):889-93.

Cavestro C, Micca G, Molinari F, Bazzan M, Di Pietrantonj C, Aloi R, Pedemonte E, Iannini R, Frigeri MC, Roccatello D. Migraineurs show a high prevalence of antiphospholipid antibodies. Journal of Thrombosis and Haemostasis. 2011 Jul 1;9(7):1350-4.

Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Khamashta MA. Features associated with epilepsy in the antiphospholipid syndrome. The Journal of Rheumatology. 2004 Jul 1;31(7):1344-8.

Cervera, R., Piette, J.C., Font, J., Khamashta, M.A., Shoenfeld, Y., Camps, M.T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I. and Galeazzi, M., 2002. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 46(4), pp.1019-1027.

Carecchio M, Cantello R, Comi C. Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage. Journal of Immunology Research. 2014;2014(1):239398.

Arnson Y, Shoenfeld Y, Alon E, Amital H. The antiphospholipid syndrome as a neurological disease. InSeminars in arthritis and rheumatism 2010 Oct 1 (Vol. 40, No. 2, pp. 97-108). WB Saunders.

Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, Minagar A, Munschauer FE, Galey TM, Hussein S, Bakshi R. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. Journal of neurology. 2010 Jan;257:63-71.

Rodrigues CE, de Carvalho JF. Clinical, radiologic, and therapeutic analysis of 14 patients with transverse myelitis associated with antiphospholipid syndrome: report of 4 cases and review of the literature. InSeminars in arthritis and rheumatism 2011 Feb 1 (Vol. 40, No. 4, pp. 349-357). WB Saunders.

Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P. Transverse myelitis in patients with antiphospholipid antibodies–the importance of early diagnosis and treatment. Clinical rheumatology. 2002 Jun;21:207-10.

Iyer A, Elsone L, Appleton R, Jacob A. A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica. Autoimmunity. 2014 May 1;47(3):154-61.

Tobin WO, Weinshenker BG, Lucchinetti CF. Longitudinally extensive transverse myelitis. Current opinion in neurology. 2014 Jun 1;27(3):279-89.

Gris JC, Cyprien F, Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Balducchi JP. Antiphospholipid antibodies are associated with positive screening for common mental disorders in women with previous pregnancy loss. The NOHA-PSY observational study. The World Journal of Biological Psychiatry. 2019 Jan 2;20(1):51-63.

Gupta S, Zivadinov R, Ramasamy D, Ambrus JL. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature. Clinical Rheumatology. 2014 Dec;33:1829-33.

Wang Z, Fu Z, Wang J, Cui H, Zhang Z, Zhang B. Moyamoya syndrome with antiphospholipid antibodies: a case report and literature review. Lupus. 2014 Oct;23(11):1204-6.

Dayama A, Dass J, Mahapatra M, Saxena R. Incidence of antiphospholipid antibodies in patients with immune thrombocytopenia and correlation with treatment with steroids in north Indian population. Clinical and Applied Thrombosis/Hemostasis. 2017 Sep;23(6):657-62.

Morchi GS, Wolfe RR, Kay JD. Antiphospholipid syndrome leading to myocardial infarction in a Fontan patient 17 years after Norwood palliation. Congenital Heart Disease. 2009 Jan;4(1):54-8.

Morchi GS, Wolfe RR, Kay JD. Antiphospholipid syndrome leading to myocardial infarction in a Fontan patient 17 years after Norwood palliation. Congenital Heart Disease. 2009 Jan;4(1):54-8.

Hancock HS, Wang M, Gist KM, Gibson E, Miyamoto SD, Mourani PM, Manco-Johnson MJ, Goldenberg NA. Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study. Cardiology in the Young. 2013 Jun;23(3):344-52.

Riccialdelli L, Arnaldi G, Giacchetti G, Pantanetti P, Mantero F. Hypertension due to renal artery occlusion in a patient with antiphospholipid syndrome. American journal of hypertension. 2001 Jan 1;14(1):62-5.

Go EJ, O’Neil KM. The catastrophic antiphospholipid syndrome in children. Current Opinion in Rheumatology. 2017 Sep 1;29(5):516-22.

Berman H, Rodríguez-Pintó I, Cervera R, Gregory S, de Meis E, Rodrigues CE, Aikawa NE, de Carvalho JF, Springer J, Niedzwiecki M, Espinosa G. Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the “CAPS Registry”. Autoimmunity Reviews. 2014 Feb 1;13(2):157-62.